Global Viral Vaccines In-Depth Monitoring and Development Analysis Report 2024
Report Code: KNJ1767835 No. of Pages: 107 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
The global Viral Vaccines market size in 2023 is xx million US dollars, and it is expected to be xx million US dollars by 2030, with a compound annual growth rate of xx% expected in 2024-2030. MARKET COMPETITIVE LANDSCAPE: The main players in the Viral Vaccines market include Merck & Co., Inc., Novartis, Inc., Emergent BioSolutions Inc., GlaxoSmithKline plc, and Serum institute of India Private Limited. The share of the top 3 players in the Viral Vaccines market is xx%. REGION SHARE: The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for xx%, Europe accounted for xx% of Viral Vaccines market, and Asia Pacific accounted for xx%. SEGMENT OVERVIEW: The report segments the market by Type and Application. Attenuated Vaccine accounted for xx% of Viral Vaccines market in 2023. Inactivated Vaccine share of xx%. Hospital accounted for xx% of the Viral Vaccines market in 2023. Clinics accounts for xx%. This Viral Vaccines market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market. Viral Vaccines market country level analysis The countries covered in the Viral Vaccines market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc. The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data. Competitive Landscape and Viral Vaccines Market Share Analysis Viral Vaccines market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Viral Vaccines market. Chapter Outline Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions. Chapters 2-7: Provide Global, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Viral Vaccines market type, application, player and country market segmentation data. Chapters 8-9: Segmented the global Viral Vaccines market by type, and application. Analyze the revenue of market segments from different perspectives. Chapter 10: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans. Chapter 11: Analyzes the main companies in the Viral Vaccines industry, including their main businesses, products/services, revenue, gross and gross margin. Chapter 12: The main points and conclusions of the report. Highlights-Regions North America United States Canada Asia Pacific China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Nordic South America Brazil Argentina Colombia Mexico Middle East & Africa Egypt South Africa Israel Turkey GCC Countries Player list Merck & Co., Inc. Novartis, Inc. Emergent BioSolutions Inc. GlaxoSmithKline plc Serum institute of India Private Limited Seqirus (CSL Limited) Pfizer, Inc. Sanofi AstraZeneca plc Novavax, Inc. Types list Attenuated Vaccine Inactivated Vaccine Application list Hospital Clinics Physician's Office Others
Table of Content 1 Viral Vaccines Market Introduction and Overview 1.1 Viral Vaccines Definition 1.2 Market Size Analysis by Types 1.3 Market Size Analysis by Application 1.4 Research Purposes 1.5 Report Timeline 1.6 Economic Analysis of Global Regions 2 Global Market Growth Trends Analysis 2.1 Global Viral Vaccines Market Size & Forecast (2019-2030) 2.2 Viral Vaccines Growth Trends Analysis by Regions 2.2.1 Viral Vaccines Market Size by Regions: 2019 VS 2024 VS 2030 2.2.2 Viral Vaccines Historic Market Size by Regions (2019-2024) 2.2.3 Viral Vaccines Forecasted Market Size by Regions (2024-2030) 2.2.4 North America Viral Vaccines Market Size & Forecast (2019-2030) 2.2.5 Europe Viral Vaccines Market Size & Forecast (2019-2030) 2.2.6 Asia-Pacific Viral Vaccines Market Size & Forecast (2019-2030) 2.2.7 Latin America Viral Vaccines Market Size & Forecast (2019-2030) 2.2.8 Middle East & Africa Viral Vaccines Market Size & Forecast (2019-2030) 3 North America 3.1 North America Viral Vaccines Revenue by Countries 3.1.1 North America Viral Vaccines Revenue by Countries (2019-2030) 3.2 North America Viral Vaccines Revenue by Players 3.3 North America Viral Vaccines Revenue by Types 3.4 North America Viral Vaccines Revenue by Applications 3.5 United States 3.6 Canada 4 Asia Pacific 4.1 Asia Pacific Viral Vaccines Revenue by Countries 4.1.1 Asia Pacific Viral Vaccines Revenue by Countries (2019-2030) 4.2 Asia Pacific Viral Vaccines Revenue by Players 4.3 Asia Pacific Viral Vaccines Revenue by Types 4.4 Asia Pacific Viral Vaccines Revenue by Applications 4.5 China 4.6 Japan 4.7 Korea 4.8 Southeast Asia 4.9 India 4.10 Australia 5 Europe 5.1 Europe Viral Vaccines Revenue by Countries 5.1.1 Europe Viral Vaccines Revenue by Countries (2019-2030) 5.2 Europe Viral Vaccines Revenue by Players 5.3 Europe Viral Vaccines Revenue by Types 5.4 Europe Viral Vaccines Revenue by Applications 5.5 Germany 5.6 France 5.7 UK 5.8 Italy 5.9 Russia 5.10 Spain 5.11 Nordic 6 Latin America 6.1 Latin America Viral Vaccines Revenue by Countries 6.1.1 Latin America Viral Vaccines Revenue by Countries (2019-2030) 6.2 Latin America Viral Vaccines Revenue by Players 6.3 Latin America Viral Vaccines Revenue by Types 6.4 Latin America Viral Vaccines Revenue by Applications 6.5 Brazil 6.6 Argentina 6.7 Colombia 6.8 Mexico 7 Middle East & Africa 7.1 Middle East & Africa Viral Vaccines Revenue by Countries 7.1.1 Middle East & Africa Viral Vaccines Revenue by Countries (2019-2030) 7.2 Middle East & Africa Viral Vaccines Revenue by Players 7.3 Middle East & Africa Viral Vaccines Revenue by Types 7.4 Middle East & Africa Viral Vaccines Revenue by Applications 7.5 Egypt 7.6 South Africa 7.7 Israel 7.8 Turkey 7.9 GCC Countries 8 Global Viral Vaccines Historical and Forecast Market Analysis by Type 8.1 Global Viral Vaccines Revenue and Market Share by Type 8.2 Global Viral Vaccines Market Forecast by Type (2024-2030) 9 Global Viral Vaccines Historical and Forecast Market Analysis by Application 9.1 Global Viral Vaccines Revenue Market Share by Application (2019-2024) 9.2 Viral Vaccines Market Forecast by Application (2024-2030) 10 Viral Vaccines Industry Dynamic Analysis 10.1 Viral Vaccines Market Trends Analysis 10.2 Viral Vaccines Market Drivers Analysis 10.3 Viral Vaccines Market Challenges Analysis 10.4 Viral Vaccines Market Restraints Analysis 10.5 Viral Vaccines Industry Mergers & Acquisitions 10.6 Viral Vaccines Industry New Entrants and Expansion Plans 11 Players Profiles 11.1 Merck & Co., Inc. 11.1.1 Merck & Co., Inc. Company Profile 11.1.2 Viral Vaccines Product Overview 11.1.3 Merck & Co., Inc. Viral Vaccines Market Performance (2019-2024) 11.1.4 Merck & Co., Inc. Business Overview 11.2 Novartis, Inc. 11.2.1 Novartis, Inc. Company Profile 11.2.2 Viral Vaccines Product Overview 11.2.3 Novartis, Inc. Viral Vaccines Market Performance (2019-2024) 11.2.4 Novartis, Inc. Business Overview 11.3 Emergent BioSolutions Inc. 11.3.1 Emergent BioSolutions Inc. Company Profile 11.3.2 Viral Vaccines Product Overview 11.3.3 Emergent BioSolutions Inc. Viral Vaccines Market Performance (2019-2024) 11.3.4 Emergent BioSolutions Inc. Business Overview 11.4 GlaxoSmithKline plc 11.4.1 GlaxoSmithKline plc Company Profile 11.4.2 Viral Vaccines Product Overview 11.4.3 GlaxoSmithKline plc Viral Vaccines Market Performance (2019-2024) 11.4.4 GlaxoSmithKline plc Business Overview 11.5 Serum institute of India Private Limited 11.5.1 Serum institute of India Private Limited Company Profile 11.5.2 Viral Vaccines Product Overview 11.5.3 Serum institute of India Private Limited Viral Vaccines Market Performance (2019-2024) 11.5.4 Serum institute of India Private Limited Business Overview 11.6 Seqirus (CSL Limited) 11.6.1 Seqirus (CSL Limited) Company Profile 11.6.2 Viral Vaccines Product Overview 11.6.3 Seqirus (CSL Limited) Viral Vaccines Market Performance (2019-2024) 11.6.4 Seqirus (CSL Limited) Business Overview 11.7 Pfizer, Inc. 11.7.1 Pfizer, Inc. Company Profile 11.7.2 Viral Vaccines Product Overview 11.7.3 Pfizer, Inc. Viral Vaccines Market Performance (2019-2024) 11.7.4 Pfizer, Inc. Business Overview 11.8 Sanofi 11.8.1 Sanofi Company Profile 11.8.2 Viral Vaccines Product Overview 11.8.3 Sanofi Viral Vaccines Market Performance (2019-2024) 11.8.4 Sanofi Business Overview 11.9 AstraZeneca plc 11.9.1 AstraZeneca plc Company Profile 11.9.2 Viral Vaccines Product Overview 11.9.3 AstraZeneca plc Viral Vaccines Market Performance (2019-2024) 11.9.4 AstraZeneca plc Business Overview 11.10 Novavax, Inc. 11.10.1 Novavax, Inc. Company Profile 11.10.2 Viral Vaccines Product Overview 11.10.3 Novavax, Inc. Viral Vaccines Market Performance (2019-2024) 11.10.4 Novavax, Inc. Business Overview 12 Research Findings and Conclusion
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com